Market Overview

15 Biggest Mid-Day Gainers For Monday

Share:
Related
Watch These 8 Huge Call Purchases In Thursday Trade
Watch These 4 Huge Call Purchases In Wednesday Trade
Related CNCE
18 Biggest Mid-Day Gainers For Monday
Concert Pharma Shares Rally Over $15 Level Following New Buy Rating, $20 Price Target
  • TG Therapeutics Inc (NASDAQ: TGTX) shares surged 88.8 percent to $10.10 after the company disclosed that Phase 3 GENUINE study met its primary endpoint.
  • Concert Pharmaceuticals Inc (NASDAQ: CNCE) shares climbed 79.5 percent to $17.32. Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced plans to acquire CTP-656 from Concert Pharma for $160 million in cash and potential $90 million in milestones.
  • Dextera Surgical Inc (NASDAQ: DXTR) shares jumped 36.8 percent to $1.56 after the company disclosed that MicroCutter 5/80 surgical stapler enabled shorter hospital stays through less invasive lobectomy.
  • ChinaCache International Holdings Ltd (NASDAQ: CCIH) shares climbed 23 percent to $2.46 as the company agreed to sell data center assets for total consideration of RMB$221.2 million.
  • Skypeople Fruit Juice Inc (NASDAQ: SPU) shares rose 18 percent to $5.93 as the company disclosed that it has entered into one-year business agreement with China Aigo O2O Technology Inc.
  • Quest Resource Holding Corp (NASDAQ: QRHC) gained 14.7 percent to $2.51. Rodman & Renshaw initiated coverage on Quest Resource with a Buy rating.
  • Novan Inc (NASDAQ: NOVN) surged 14.1 percent to $7.29. Novan announced plans to continue SB204 development program.
  • NXT-ID Inc (NASDAQ: NXTD) shares rose 13.1 percent to $2.07.
  • Polar Power Inc (NASDAQ: POLA) shares gained 12.5 percent to $9.88 after the company reported 2016 financial results.
  • Ever-Glory International Group Inc (NASDAQ: EVK) shares surged 12 percent to $2.80.
  • Bellerophon Therapeutics Inc (NASDAQ: BLPH) shares gained 9 percent to $1.53.
  • Advaxis, Inc. (NASDAQ: ADXS) rose 7.4 percent to $9.90 after the company reported the FDA acceptance of IND for ADXS-NEO. The company announced plans to initiate Phase 1 trial in 2017.
  • Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 7.1 percent to $5.15 after gaining 6.18 percent on Friday.
  • Minerva Neurosciences Inc (NASDAQ: NERV) shares surged 5.4 percent to $8.75. Jefferies initiated coverage on Minerva Neurosciences with a Buy rating.
  • PTC Therapeutics, Inc. (NASDAQ: PTCT) shares gained 4 percent to $10.20. PTC Therapeutics reported FDA acknowledgment of NDA filing for Translarna.

Latest Ratings for TGTX

DateFirmActionFromTo
Apr 2017JefferiesInitiates Coverage OnBuy
Mar 2017H.C. WainwrightReiteratesBuy
Feb 2017Aegis CapitalInitiates Coverage OnBuy

View More Analyst Ratings for TGTX
View the Latest Analyst Ratings

Posted-In: Mid-Day GainersNews Intraday Update Analyst Ratings Movers

 

Related Articles (ADXS + AUPH)

View Comments and Join the Discussion!
Loading...
Loading...